Cisplatin Treatment Options in United Kingdom (Updated 8/25)

Pembrolizumab in Biliary Tract Cancer

NCT03260712

Completed

This is a single-arm, multi-centre, phase II study in biliary tract cancer (BTC) patients. The main objective is to detect an increase in progression-free survival rate at 6 months (according to RECIST version 1.1) from 60% in patients with BTC treated with standard chemotherapy (CT) approach to 75% when treated with CT combined with pembrolizumab.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/02/2023

Locations: Universitaetsklinikum Leipzig UCCL-Krebszentrum, Leipzig, Not set +6 locations

Conditions: Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer, Gallbladder Cancer

Register for Updates

Learn More ›

Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC

NCT04066491

Terminated

Study consisted of an open-label, safety run-in part and a randomized, double-blind, placebo-controlled Phase 2/3 part. In the Phase 2/3 part, the study was evaluated whether bintrafusp alfa in combination with the current standard of care (SoC) (gemcitabine plus cisplatin) improves overall survival (OS) in chemotherapy and immunotherapy-naïve participants with locally advanced or metastatic Biliary Tract Cancer (BTC) compared to placebo, gemcitabine and cisplatin.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

10/26/2023

Locations: Ironwood Cancer & Research Centers - Chandler II, Chandler, Arizona +98 locations

Ironwood Cancer & Research Centers - Chandler II, Chandler, Arizona

Banner MD Anderson Cancer Center, Gilbert, Arizona

Mayo Clinic Arizona, Phoenix, Arizona

Beverly Hills Cancer Center, Beverly Hills, California

Mayo Clinic in Florida - Department of Neurology, Jacksonville, Florida

Mount Sinai Medical Center, Miami Beach, Florida

University of Kansas Medical Center Research Institute, Inc. - University of Kansas Cancer Center/Bloch Pavilion, Westwood, Kansas

Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, Maryland

Mayo Clinic - Rochester, Rochester, Minnesota

Methodist Transplant Physicians, Dallas, Texas

MD Anderson Cancer Center - Unit 429, Houston, Texas

Renovatio Clinical - CENTRAL SITE, The Woodlands, Texas

Hospital de Gastroenterologia Dr. Carlos Bonorino Udaondo, Ciudad Autonoma Buenos Aires, Not set

Instituto de Investigaciones Metabolicas (IDIM), Ciudad Autonoma Buenos Aires, Not set

Instituto Medico Especializado Alexander Fleming, Ciudad Autonoma Buenos Aires, Not set

Centro Oncologico Riojano Integral (CORI), La Rioja, Not set

CEDIT, Salta, Not set

Centro Medico San Roque S.R.L., San Miguel de Tucuman, Not set

Fundacion ARS Medica, San Salvador de Jujuy, Not set

Blacktown Hospital - PARENT, Blacktown, Not set

Monash Health, Clayton, Not set

Epworth Freemasons, Melbourne, Not set

Icon Cancer Care South Brisbane, South Brisbane, Not set

Hospital de Câncer de Barretos - Fundação Pio XII, Barretos, Not set

INCA - Instituto Nacional de Câncer, Rio de Janeiro, Not set

CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia, Santo André, Not set

Fundação Faculdade Regional de Medicina de São José do Rio Preto, Sao Jose Rio Preto, Not set

A. C. Camargo Cancer Center, São Paulo, Not set

ICESP - Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira, São Paulo, Not set

IC la serena Research, La Serena, Not set

Centro de Investigación Clínica Bradford Hill, Santiago, Not set

Hospital Clínico Universidad de Chile, Santiago, Not set

Prosalud, Santiago, Not set

Instituto Clinico Oncologico del Sur (ICOS), Temuco, Not set

Beijing Cancer Hospital, Beijing, Not set

Beijing Chao Yang Hospital, Beijing, Not set

Beijing Friendship Hospital, Capital Medical University, Beijing, Not set

West China Hospital, Sichuan University, Chengdu, Not set

Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, Not set

The Affiliated Hospital of Qingdao University, Qingdao, Not set

Fudan University Shanghai Cancer Hospital, Shanghai, Not set

The Second Affiliated Hospital of Soochow University, Suzhou, Not set

Tianjin Medical University Cancer Institute & Hospital, Tianjin, Not set

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Not set

ICO - Site Paul Papin - service d'oncologie medicale, Angers Cedex 2, Not set

Centre Georges François Leclerc - Oncologie Médicale, Dijon cedex, Not set

CHU Lille - Hôpital Claude Huriez, Lille cedex, Not set

ICO - Site René Gauducheau, Saint Herblain, Not set

CHU de Toulouse - Hôpital Ranguei, Toulouse Cedex 9, Not set

Vivantes Klinikum Neukoelln - Haematologie und Onkologie, Berlin, Not set

Universitaetsklinikum Bonn AoeR - Medizinische Klinik I Gastroenterologie, Bonn, Not set

Universitaetsklinikum Carl Gustav Carus TU Dresden - Medizinische Klinik I, Dresden, Not set

Klinikum der Johann Wolfgang Goethe-Universitaet, Frankfurt, Not set

Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz - Medizinische Klinik I - HCC Ambulanz, Mainz, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Milano, Not set

IOV - Istituto Oncologico Veneto IRCCS - S.Semplice Dip.Oncologia dei Melanomi, Padova, Not set

Università Campus Bio-Medico di Roma, Roma, Not set

Azienda Ospedaliera Universitaria Integrata Verona (Ospedale Borgo Roma) - UOC Oncologia, Verona, Not set

Chiba Cancer Center, Chiba-shi, Not set

National Cancer Center Hospital - Dept of Hepatobiliary and Pancreatic Oncology, Chuo-ku, Not set

NHO Kyushu Cancer Center - Dept of Gastroenterology/Hepatology/Pancreatology, Fukuoka-shi, Not set

National Cancer Center Hospital East, Kashiwa-shi, Not set

Cancer Institute Hospital of JFCR - Dept of Hepato,Biliary and Pancreatic Medicine, Koto-ku, Not set

Kyorin University Hospital, Mitaka-shi, Not set

Aichi Cancer Center Hospital, Nagoya-shi, Not set

Osaka City University Hospital, Osaka-shi, Not set

Kindai University Hospital, Osakasayama-shi, Not set

Kanagawa Cancer Center, Yokohama-shi, Not set

Chungnam National University Hospital - Department of Internal Medicine (Rheumatology), Daejeon, Not set

Seoul National University Bundang Hospital, Seongnam-si, Not set

Asan Medical Center, Seoul, Not set

Korea University Anam Hospital, Seoul, Not set

Korea University Guro Hospital, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Seoul National University Hospital, Seoul, Not set

Severance Hospital, Yonsei University Health System, Seoul, Not set

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Not set

Centrum Onkologii-Instytut im.M.Sklodowskiej Curie, Gliwice, Not set

Pratia, Krakow, Not set

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Warszawa, Not set

ETG Zamosc, Zamosc, Not set

Hospital Clinic i Provincial de Barcelona - Servicio de Oncologia, Barcelona, Not set

Hospital Universitari Vall d'Hebron - Dept of Oncology, Barcelona, Not set

Hospital San Pedro de Alcantara - Servicio de Oncologia, Caceres, Not set

Hospital Universitario Reina Sofia - Dept of Oncology, Cordoba, Not set

ICO l´Hospitalet - Hospital Duran i Reynals, L'Hospitalet de Llobregat, Not set

Hospital General Universitario Gregorio Marañon - Servicio de Oncologia Medica, Madrid, Not set

Hospital Universitario Clinico San Carlos - Servicio de Oncologia, Madrid, Not set

Hospital Universitario HM Madrid Sanchinarro - Servicio de Oncologia, Madrid, Not set

Hospital Clinico Universitario de Valencia - Servicio de Hematologia y Oncologia Medica, Valencia, Not set

Hospital Universitari i Politecnic La Fe - Servicio de Oncologia Medica, Valencia, Not set

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Not set

China Medical University Hospital, Taichung, Not set

Taichung Veterans General Hospital, Taichung, Not set

National Cheng Kung University Hospital, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Chang Gung Memorial Hospital, Linkou, Taoyuan, Not set

The Christie - Dept of Oncology, Manchester, Not set

Conditions: Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer

Register for Updates

Learn More ›

Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer

NCT05318794

Not Yet Recruiting

Data demonstrating the efficacy of PIPAC in patients with regionally advanced gastric cancer with positive peritoneal cytology and/or minimal peritoneal disease is limited due to the relatively recent development of this technique and its historical preferential use in palliative patients with disseminated peritoneal metastasis. Existing data suggest PIPAC administered every six weeks in conjunction with standard treatment may work as an adjunct to conventional systemic neoadjuvant chemotherapy... Read More

Gender:

ALL

Ages:

All

Trial Updated:

09/12/2023

Locations: Imperial College London, Hammersmith Hospital Campus, London, Not set

Conditions: Gastric Cancer, Peritoneal Metastases, Chemotherapy Effect

Register for Updates

Learn More ›

Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

NCT02709512

Completed

This is a study of ADI-PEG 20 (pegylated arginine deiminase), an arginine degrading enzyme versus placebo in patients with malignant pleural mesothelioma. Malignant pleural mesothelioma have been found to require arginine, an amino acid. Thus the hypothesis is that by restricting arginine with ADI-PEG 20, the malignant pleural mesothelioma cells will starve and die.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

09/09/2023

Locations: Mayo Clinic, Phoenix, Arizona +44 locations

Mayo Clinic, Phoenix, Arizona

UCLA Hematology & Oncology - Santa Monica, Los Angeles, California

University of California San Francisco Helen Diller Comprehensive Cancer Center, San Francisco, California

H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida

University of Chicago, Chicago, Illinois

University of Maryland, Marlene & Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland

Henry Ford Hospital, Detroit, Michigan

Mayo Clinic, Rochester, Minnesota

Memorial Sloan Kettering Cancer Center, New York, New York

MD Anderson Cancer Center, Houston, Texas

Chris O'Brien Lifehouse, Camperdown, New South Wales

Tweed Hospital (NNSW LHD), Tweed Heads, New South Wales

Princess Alexandria Hospital and Health Services, Woolloongabba, Queensland

Southern Adelaide Local Health Network, Inc., Bedford Park, South Australia

Austin Health, Heidelberg, Victoria

Sir Charles Gairdner Hospital, Perth, Western Australia

SS. Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, AL

Humanitas Gavazzeni, Bergamo, BG

Ospedale Villa Scassi, Genova, GE

Azienda Ospedaliera San Gerardo - Monza, Chirurgia Toracica, Monza, MB

European Institute of Oncology, Milano, MI

Fondazione IRCCS Policlinico San Matteo, Pavia, PV

Fondazione IRCCS - Istituto Nazionale dei Tumori Milano, Milan, Not set

Azienda Ospedaliero Universitaria di Parma, Parma, Not set

Azienda Ospedaliero Universitaria Pisana, Pisa, Not set

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Not set

Chang Gung Medical Foundation Kaohsiung, Kaohsiung, Not set

Taichung Veterans General Hospital, Taichung, Not set

National Taiwan University Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Chang Gung Memorial Foundation LinKou Branch, Taoyuan, Not set

Addenbrooke's Hospital, Cambridge, Cambridgeshire

Plymouth Hospitals (Derriford Hospital), Plymouth, Devon

Centre for Experimental Cancer Medicine (CECM), London, England

Southampton General Hospital, Southampton, Hampshire

University Hospitals Leicester, Leicester, Leicestershire

Scunthorpe General Hospital, Scunthorpe, North Lincolnshire

Wansbeck General Hospital, Ashington, Northumberland

Oxford Cancer and Haematology Centre, The Churchill Hospital, Oxford, Oxfordshire

Velindre Cancer Centre, Cardiff, Not set

Edinburgh Cancer Centre, Edinburgh, Not set

Beatson West of Scotland Cancer Centre, Glasgow, Not set

St James's University Hospital, Leeds, Not set

St Bartholomew's Hospital, London, Not set

University Hospital of South Manchester, Manchester, Not set

Conditions: Mesothelioma

Register for Updates

Learn More ›

Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT02741570

Completed

The main purpose of this study is to compare nivolumab and ipilimumab with the extreme regimen as first line treatment in patients with recurrent or metastatic squamous cell of the head and neck cancer

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/31/2023

Locations: Local Institution - 0134, Tucson, Arizona +132 locations

Local Institution - 0134, Tucson, Arizona

Local Institution - 0135, Duarte, California

Local Institution - 0005, Stanford, California

Local Institution - 0028, Jacksonville, Florida

Local Institution - 0008, Tampa, Florida

Local Institution - 0111, Atlanta, Georgia

Local Institution - 0006, Chicago, Illinois

Local Institution - 0001, Boston, Massachusetts

Local Institution - 0080, Boston, Massachusetts

Local Institution - 0093, Boston, Massachusetts

Local Institution - 0004, Ann Arbor, Michigan

Local Institution - 0012, Charlotte, North Carolina

Local Institution - 0007, Columbus, Ohio

Local Institution - 0010, Langhorne, Pennsylvania

Local Institution - 0015, Philadelphia, Pennsylvania

Local Institution - 0013, Pittsburgh, Pennsylvania

Local Institution - 0139, Dallas, Texas

Local Institution - 0009, Houston, Texas

Local Institution - 0014, Houston, Texas

Local Institution - 0003, Charlottesville, Virginia

Local Institution - 0011, Fairfax, Virginia

Local Institution - 0125, Morgantown, West Virginia

Local Institution - 0142, Blacktown, New South Wales

Local Institution - 0127, Darlinghurst, New South Wales

Local Institution - 0128, Gosford, New South Wales

Local Institution - 0019, St. Leonards, New South Wales

Local Institution - 0077, Brisbane, Queensland

Local Institution - 0036, Douglas, Queensland

Local Institution - 0021, Elizabeth Vale, South Australia

Local Institution - 0022, Clayton, Victoria

Local Institution - 0131, Melbourne, Victoria

Local Institution - 0020, Nedlands, Western Australia

Local Institution - 0075, Linz, Not set

Local Institution - 0071, Wien, Not set

Local Institution - 0148, Belo Horizonte, Minas Gerais

Local Institution - 0121, Ijui, RIO Grande DO SUL

Local Institution - 0122, Porto Alegre, RIO Grande DO SUL

Local Institution - 0120, Porto Alegre, RIO Grande DO SUL

Local Institution - 0117, Barretos, Sao Paulo

Local Institution - 0123, Sao Jose De Rio Preto, Sao Paulo

Local Institution - 0118, Sao Paulo, Not set

Local Institution - 0124, Sao Paulo, Not set

Local Institution - 0133, Amiens, Somme

Local Institution - 0094, Bordeaux, Not set

Local Institution - 0140, La Tronche, Not set

Local Institution - 0090, Lille, Not set

Local Institution - 0138, Lyon, Not set

Local Institution - 0054, Lyon, Not set

Local Institution - 0126, Marseille, Not set

Local Institution - 0055, Nice Cedex 2, Not set

Local Institution - 0039, Paris, Not set

Local Institution - 0088, Paris, Not set

Local Institution, Paris, Not set

Local Institution - 0089, Strasbourg, Not set

Local Institution - 0040, Villejuif Cedex, Not set

Local Institution - 0068, Bonn, Not set

Local Institution - 0078, Freiburg, Not set

Local Institution - 0067, Hamburg, Not set

Local Institution - 0092, Hannover, Not set

Local Institution - 0079, Heidelberg, Not set

Local Institution - 0074, Leipzig, Not set

Local Institution - 0070, Mainz, Not set

Local Institution - 0065, Muenchen, Not set

Local Institution - 0069, Ulm, Not set

Local Institution - 0066, Wuerzburg, Not set

Local Institution - 0018, Athens, Not set

Local Institution - 0017, Nea Kifissia, Not set

Local Institution - 0051, Thessaloniki, Not set

Local Institution - 0147, Dublin 8, Dublin

Local Institution - 0062, Haifa, Not set

Local Institution - 0060, Jerusalem, Not set

Local Institution - 0063, Petah-tikva, Not set

Local Institution - 0061, Ramat-gan, Not set

Local Institution - 0064, Tel-Aviv, Not set

Local Institution - 0042, Milano, MI

Local Institution - 0043, Torino, TO

Local Institution - 0044, Cuneo, Not set

IRST Meldola, Meldola (fc), Not set

Azienda Ospedaliera Universitaria Di Modena, Modena, Not set

Aorn Dei Colli, Napoli, Not set

Istituto Nazionale Tumori Fondazione Pascale, Napoli, Not set

Azienda Ospedaliera Di Perugia, Perugia, Not set

Fondazione Policlinico Universitario A. Gemelli, Roma, Not set

Local Institution - 0106, Nagoya, Aichi

Local Institution - 0100, Kashiwa, Chiba

Local Institution - 0113, Fukuoka-shi, Fukuoka

Local Institution - 0105, Sapporo-shi, Hokkaido

Local Institution - 0107, Akashi-shi, Hyogo

Local Institution - 0102, Kobe-shi, Hyogo

Local Institution - 0152, Isehara, Kanagawa

Local Institution - 0150, Yokohama-shi, Kanagawa

Local Institution - 0151, Natori-shi, Miyagi

Local Institution - 0108, Sendai-shi, Miyagi

Local Institution - 0146, Osakasayaha, Osaka

Local Institution - 0099, Takatsuki-shi, Osaka

Local Institution - 0149, Kitaadachi-gun, Saitama

Local Institution - 0114, Sunto-gun, Shizuoka

Local Institution, Shimotsuke-shi, Tochigi

Local Institution - 0153, Bunkyo-ku, Tokyo

Local Institution - 0101, Chuo-ku, Tokyo

Local Institution - 0104, Koto-ku, Tokyo

Local Institution - 0109, Kita-gun, Not set

Local Institution - 0096, Gangnam-gu, Not set

Local Institution - 0110, Seoul, Not set

Local Institution - 0095, Seoul, Not set

Local Institution - 0034, Mexico City, Distrito Federal

Local Institution - 0030, Mexico, Distrito Federal

Local Institution - 0032, Leon de los Aldama, Guanajuato

Local Institution - 0031, Morelia, Michoacan

Local Institution - 0033, Monterrey, Nuevo LEON

Local Institution - 0035, Oaxaca, Not set

Local Institution - 0037, Bydgoszcz, Not set

Local Institution - 0023, Gdansk, Not set

Local Institution - 0129, Gliwice, Not set

Local Institution - 0026, Krakow, Not set

Local Institution - 0025, Warszawa, Not set

Local Institution - 0083, Barcelona, Not set

Local Institution - 0130, L'Hospitalet Del Llobregat, Not set

Local Institution - 0085, Madrid, Not set

Local Institution - 0082, Madrid, Not set

Local Institution - 0084, Sevilla, Not set

Local Institution - 0081, Valencia, Not set

Local Institution - 0072, Basel, Not set

Local Institution - 0073, Zuerich, Not set

Local Institution - 0097, Taichung, Not set

Local Institution - 0098, Taipei, Not set

Local Institution - 0049, Newcastle Upon Tyne, Durham

Local Institution - 0045, London, Greater London

Local Institution - 0046, Manchester, Greater Manchester

Local Institution - 0047, Southampton, Hampshire

Local Institution - 0091, Sutton, Surrey

Local Institution - 0050, Birmingham, West Midlands

Local Institution - 0132, Sheffield, Not set

Conditions: Head and Neck Cancer

Register for Updates

Learn More ›

Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies

NCT03317496

Terminated

This is a Phase 1b/2, open label, multicenter, safety and clinical activity study of avelumab in combination with chemotherapy as first-line treatment of adult patients with locally advanced or metastatic solid tumors. Initially, avelumab will be evaluated in combination with pemetrexed and carboplatin in patients with advanced non-squamous non-small cell lung cancer (NSCLC) (Cohort A1) and in combination with gemcitabine and cisplatin in patients with cisplatin-eligible urothelial (bladder) can... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/04/2023

Locations: University of Arizona Cancer Center - North Campus, Tucson, Arizona +45 locations

University of Arizona Cancer Center - North Campus, Tucson, Arizona

Banner-University Medical Center Tucson, Tucson, Arizona

Montefiore Medical Center - Einstein Center for Cancer Care, Bronx, New York

Montefiore Medical Center - Moses Division, Bronx, New York

Stony Brook Cancer Center, Stony Brook, New York

Stony Brook University, Stony Brook, New York

Duke University Medical Center/Duke Cancer Center, Durham, North Carolina

Investigational Chemotherapy Service, Durham, North Carolina

Chris O'Brien Lifehouse, Camperdown, New South Wales

St Vincent's Hospital Sydney, Darlinghurst, New South Wales

St Vincent's Public Hospital Sydney, Darlinghurst, New South Wales

Western Health, Sunshine Hospital, St Albans, Victoria

Kingston Health Sciences Centre -, Kingston, Ontario

Fakultni nemocnice Olomouc, Klinika nuklearni mediciny, Olomouc, Not set

Fakultni nemocnice Olomouc, Ustav klinicke a molekularni patologie, Olomouc, Not set

Fakultni nemocnice Olomouc, Olomouc, Not set

Thomayerova nemocnice, Prague, Not set

Centrum nuklearni mediciny s.r.o., Prague, Not set

Vseobecna fakultni nemocnice v Praze, Praha 2, Not set

Orszagos Onkologiai Intezet "C" Belgyogyaszati - Onkologiai es Klinikai Farmakologiai Osztaly, Budapest, Not set

AOU Ospedali Riuniti di Ancona Umberto I - GM Lancisi - G Salesi, Torrette Di Ancona, AN

IRCCS Istit.Scient.Romagnolo per lo Studio e la Cura dei Tumori, Meldola, FC

Centro di Ricerca di Fase 1, ASST Monza-Ospedale San Gerardo, Monza, MB

Oncologia, ASST Monza-Ospedale San Gerardo, Monza, MB

Istituto Europeo di Oncologia (IEO), Milano, MI

Istituto Nazionale Tumori di Napoli IRCCS Fondazione Pascale, Napoli, Not set

Hospital Universitario Vall d'Hebron, Barcelona, Not set

Hospital Clinic I Provincial, Barcelona, Not set

Hospital Universitario Fundacion Jimenez Diaz, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Fundacion Instituto Valenciano de Oncologia, Valencia, Not set

Royal Cornwall Hospital, Truro, Cornwall

The Platinum Medical Centre, London, England

The Wellington Hospital - South, London, England

Sarah Cannon Research Institute UK, London, England

The Harley Street Clinic, London, England

HCA Pharmacy Department, London, England

The Harley Street Clinic, London, England

The Princess Grace Hospital, London, England

Weston Park Hospital, Sheffield, South Yorkshire

Sir Bobby Robson Cancer Trials Research Centre, Newcastle upon Tyne, Not set

Conditions: Non-small Cell Lung Cancer, Urothelial Cancer

Register for Updates

Learn More ›

Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer

NCT00993655

Completed

RATIONALE: Drugs used in chemotherapy, such as paclitaxel, carboplatin, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) and giving them in different ways may kill more tumor cells. It is not yet known which combination chemotherapy regimen is more effective in treating patients with ovarian epithelial cancer, primary peritoneal cancer, and fallopian tube ca... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

08/03/2023

Locations: Mercy-Springfield, Springfield, Missouri +49 locations

Mercy-Springfield, Springfield, Missouri

CoxHealth, Springfield, Missouri

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Women and Infants Hospital of Rhode Island, Providence, Rhode Island

Univ of Utah (Huntsman Cancer Institute), Salt Lake City, Utah

Northwest CCOP - Multicare Health System, Tacoma, Washington

Tom Baker Cancer Centre, Calgary, Alberta

Cross Cancer Institute, Edmonton, Alberta

BCCA - Cancer Centre for the Southern Interior, Kelowna, British Columbia

BCCA - Fraser Valley Cancer Centre, Surrey, British Columbia

BCCA - Vancouver Cancer Centre, Vancouver, British Columbia

CancerCare Manitoba, Winnipeg, Manitoba

Regional Health Authority B, Zone 2, Saint John, New Brunswick

Dr. H. Bliss Murphy Cancer Centre, St. John's, Newfoundland and Labrador

QEII Health Sciences Centre, Halifax, Nova Scotia

Cancer Centre of Southeastern Ontario at Kingston, Kingston, Ontario

London Regional Cancer Program, London, Ontario

Ottawa Hospital Research Institute, Ottawa, Ontario

Thunder Bay Regional Health Science Centre, Thunder Bay, Ontario

Univ. Health Network-Princess Margaret Hospital, Toronto, Ontario

Hopital Maisonneuve-Rosemont, Montreal, Quebec

CHUM - Hopital Notre-Dame, Montreal, Quebec

McGill University - Dept. Oncology, Montreal, Quebec

CHUQ-Pavillon Hotel-Dieu de Quebec, Quebec City, Quebec

Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec

Instituto Catalan de Oncologia - L'Hospitalet, Hospitalet de Llobregat, Barcelona

Hospital Fundacion Alcorcon, Alcorcon, Madrid

Hospital Vall d'Hebron, Barcelona, Not set

Corporacio Sanitaria Clinic, Barcelona, Not set

Hospital de la Santa Creu i Sant Pau, Barcelona, Not set

Hospital Gregorio Maranon, Madrid, Not set

Centro Oncologico MD Anderson - Madrid, Madrid, Not set

Hospital Clinico San Carlos, Madrid, Not set

Fundacion Instituto Valenciano de Oncologia, Valencia, Not set

Hospital Clinico Universitario de Valencia, Valencia, Not set

The Clatterbridge Center for Oncology - Liverpool, Wirral, Bebington

Mount Vernon Hospital - Middlesex, Middlesex, Northwood

St. George's Hospital - London, London, Tooting

Wexham Park Hospital, Slough, Wexham

The Christie Hospital - Manchester, Manchester, Withington

The Western General Hospital - Edinburgh, Edinburgh, Not set

St. James University Hospital - Leeds, Leeds, Not set

Liverpool Women's Hospital - Liverpool, Liverpool, Not set

St. Bartholomew's Hospital - London, London, Not set

The Royal Marsden Hospital - London, London, Not set

The Hammersmith Hospital - London, London, Not set

University College London Hospital - London, London, Not set

St Marys Hospital - Manchester, Manchester, Not set

The Churchill Hospital - Oxford, Oxford, Not set

The Derriford Hospital - Plymouth, Plymouth, Not set

Conditions: Fallopian Tube Cancer, Metastatic Cancer, Ovarian Cancer, Peritoneal Cavity Cancer

Register for Updates

Learn More ›

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

NCT02797977

Completed

The purpose of this clinical study is to establish the safety profile, determine the maximum tolerated dose (MTD) and recommend a Phase 2 dose (RP2D) and schedule of SRA737 in combination with low dose gemcitabine; and to evaluate the efficacy of SRA737 in combination with low dose gemcitabine in prospectively-selected subjects with genetically-defined tumors that have predicted sensitivity to Chk1 inhibition based on factors including: genetic profiling of tumor tissue or ctDNA, HPV status, and... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/20/2023

Locations: Hospital Universitario Vall d'Hebron, Barcelona, Not set +19 locations

Conditions: Advanced Solid Tumors

Register for Updates

Learn More ›

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

NCT02855944

Completed

The purpose of this study is to determine how patients with ovarian, fallopian tube, and primary peritoneal cancer will best respond to treatment with rucaparib versus chemotherapy.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

06/07/2023

Locations: Rocky Mountain Cancer Center, Denver, Colorado +76 locations

Rocky Mountain Cancer Center, Denver, Colorado

Augusta University, Augusta, Georgia

Hospital Haroldo Juacaba Instituto do Cancer do Ceara, Fortaleza, Ceara

Instituto de Oncologia do Parana (IOP), Curitiba, Parana

União Brasileira de Educação e Assistência / Hospital São Lucas da PUCRS, Porto Alegre, RIO Grande DO SUL

CEPON-Centro de pesquisas Oncologicas, Florianópolis, Santa Catarina

Hospital do Cancer de Barretos, Barretos, SAO Paulo

Instituto Nacional de Câncer Hospital do Câncer II, Rio de Janeiro, Not set

Hospital Pérola Byington - Centro de Referência da Saúde da Mulher, Sao Paulo, Not set

Hospital São Camilo, Sao Paulo, Not set

Tom Baker Cancer Center, Calgary, Alberta

The Ottawa Hospital - General Campus, Ottawa, Ontario

Princess Margaret Hospital, Toronto, Ontario

Centre Hospitalier de L'Universite de Montreal (CHUM), Montreal, Quebec

CIUSSS de l'Estrie CHUS, Sherbrooke, Quebec

Masarykuv Onkologicky Ustav, Oddeleni komplexni klinicke onkologie, Brno, Jihormoravsky KRAJ

Fakultni Nemocnice v Motole, Praha 5, Praha

Fakultní Nemocnice Ostrava, Ostrava, Not set

Všeobecná Fakultní Nemocnice v Praze, Praha, Not set

Debreceni Egyetem Klinikai Központ, Debrecen, Hajdu-bihar

Országos Onkológiai Intézet, Budapest, Not set

Carmel Medical Center, Haifa, Not set

Edith Wolfson Medical Center, Holon, Not set

Hadassah Medical Organization, Jerusalem, Not set

Rabin Medical Center, Petach-Tikva, Not set

Chaim Sheba Medical Center, Ramat Gan, Not set

Tel Aviv Sourasky Medical Center, Oncology Dept., Tel Aviv, Not set

Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi, Bologna, Not set

Istituto per la Ricerca e la Cura del Cancro Istituto di Candiolo, Candiolo, Not set

AO per l'emergenza Cannizzaro, Catania, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Not set

Istituto Europeo di Oncologia, Milano, Not set

Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Not set

Istituto Nazionale per lo studio e la cura dei tumori "Fondazione Pascale" Oncologia Medica, Napoli, Not set

Fondazione Policlinico Universitario Agostino Gemelli, Roma, Not set

Niepubliczny Zaklad Opieki Zdrowotnej Innowacyjna Medycyna Sp z o.o., Grzybnica, West Pomeranian Voivodeship

Bialostockie Centrum Onkologii im. Marii Sklodowskiej-Curie, Bialystok, Not set

Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie, Lublin, Not set

Wojewodzki Szpital Specjalistyczny w Olsztynie, Olsztyn, Not set

Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Pozna, Poznan, Not set

Pomorska Akademia Medyczna w Szczecinie, Samodzielny Publiczny Szpital Kliniczny Nr 2, Szczecin, Not set

Arkhangelsk Clinical Oncological Dispensary, Arkhangelsk, Not set

Kursk Regional Oncologic Dispensary, Kursk, Not set

Moscow Clinical Scientific and Practical Center of Moscow Healthcare Department, Moscow, Not set

Omsk Region Clinical Oncologic Dispensary, Omsk, Not set

Pyatigorsk Oncological Dispensary, Pyatigorsk, Not set

Ryazan Regional Clinical Oncology Dispensary, Ryazan, Not set

Pavlov First Saint-Petersburg State Medical University, Saint Petersburg, Not set

State Healthcare Institution Oncologic Dispensary No. 2 - Health Department of Krasnodar Region, Saint Petersburg, Not set

Saint Petersburg City Oncological Dispensary, Saint-Petersburg, Not set

Republican oncological dispensary of Republic of Mordovia, Saransk, Not set

State Healthcare Institution Oncologic Dispensary No. 2 - Health Department of Krasnodar Region, Sochi, Not set

Republic Clinical Oncology Dispensary of the Ministry of Healthcare of Republic of Bashkortostan, Ufa, Not set

Hospital Duran i Reynals, Barcelona, Not set

Hospital Universitari Vall DHebron, Barcelona, Not set

Hospital Universitari de Girona Doctor Josep Trueta, Girona, Not set

Centro Oncologico Regional de Galicia, La Coruna, Not set

Hospital Clinico San Carlos, Madrid, Not set

Hospital Universitario Ramón y Cajal, Madrid, Not set

MD Anderson Cancer Center, Madrid, Not set

Universidad Autonoma de Madrid (UAM) - Hospital Universitario La Paz, Madrid, Not set

Dnipropetrovsk City Multifield Clinical Hospital Number 4, Dnipropetrovsk, Not set

National Cancer Institute of the Ministry of Health of Ukraine, Kyiv, Not set

Volyn Regional Oncology Dispensary, Lutsk, Not set

Lviv Regional Oncology Dispensary, Lviv, Not set

Sumy Regional Oncology Center, Sumy, Not set

Zakarpattya Regional Clinical Oncological Dispensary, Uzhgorod, Not set

The Christie NHS Foundation Trust - Clinical Trial Pharmacy, Manchester, England

The Royal Marsden NHS Foundation Trust, Sutton, Surrey

Cambridge University Hospitals NHS Foundation Trust, Cambridge, Not set

Velindre NHS Trust, Cardiff, Not set

University Hospital of Coventry and Warwickshire NHS Trust, Coventry, Not set

Derby Teaching Hospital NHS Foundation Trust, Derby, Not set

NHS Greater Glasgow and Clyde, Glasgow, Not set

University College London Hospitals, London, Not set

East and North Hertfordshire NHS Trust, Middlesex, Not set

Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, Not set

Conditions: Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer

Register for Updates

Learn More ›

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

NCT04163900

Terminated

NuTide:121 compares NUC-1031 with gemcitabine, both in combination with cisplatin, in patients with previously untreated advanced biliary tract cancer. The primary hypotheses are: * The combination of NUC-1031 plus cisplatin prolongs overall survival compared to the gemcitabine plus cisplatin standard of care * The combination of NUC-1031 plus cisplatin increases overall response rate compared to the gemcitabine plus cisplatin standard of care

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/22/2023

Locations: Arizona Oncology Associates , PC - HOPE, Tucson, Arizona +124 locations

Arizona Oncology Associates , PC - HOPE, Tucson, Arizona

University of Arizona Cancer Center, Tucson, Arizona

The Oncology Institute of Hope and Innovation, Whittier, California

Rocky Mountain Cancer Centers, LLP- Aurora, Aurora, Colorado

Baptist Health Medical Group Oncology, LLC, Miami, Florida

Orlando Health, Inc., Orlando, Florida

IACT Health, Columbus, Georgia

Affiliated Oncologists LLC, Chicago Ridge, Illinois

University of Kansas Medical Center Research Institute, Inc., Westwood, Kansas

Norton Cancer Institute, Louisville, Kentucky

Massachusetts General Hospital, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Henry Ford Medical Group, Detroit, Michigan

Minnesota Oncology Hemtology, Minneapolis, Minnesota

Regents of the University of Minnesota, Minneapolis, Minnesota

University of Rochester Medical Center - Strong Memorial Hospital, Rochester, New York

The Research Foundation for The State University of New York, Stony Brook, New York

Wake Forest University Health Sciences, Winston-Salem, North Carolina

The Ohio State University James Cancer Hospital and Solove Research Institute, Columbus, Ohio

Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania

Prisma Health Upstate, Greenville, South Carolina

Texas Oncology, P.A. - Austin, Austin, Texas

Baylor Charles A. Sammons Cancer Center, Dallas, Texas

Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas

Texas Oncology, P.A. - Tyler, Tyler, Texas

Virginia Mason Medical Center, Seattle, Washington

Northwest Cancer Specialists, P.C.-Vancouver, Vancouver, Washington

Wenatchee Valley Hospital and Clinics, Wenatchee, Washington

The Medical College of Wisconsin, Inc., Milwaukee, Wisconsin

Chris O'Brien Lifehouse, Camperdown, New South Wales

St George Hospital, Kogarah, New South Wales

Newcastle Private Hospital, Newcastle, New South Wales

Westmead Hospital, Westmead, New South Wales

Townsville Cancer Centre, Townsville, Queensland

Warringal Medical Centre, Heidelberg, Victoria

The Alfred Hospital, Melbourne, Victoria

Fiona Stanley Hospital, Murdoch, Western Australia

Sir Charles Gairdner Hospital, Nedlands, Western Australia

Tom Baker Cancer Centre, Calgary, Alberta

Nova Scotia Health Authority, Halifax, Nova Scotia

Royal Victoria Regional Health Centre, Barrie, Ontario

The Ottawa Hospital Cancer Centre, Ottawa, Ontario

Sunnybrook Research Institute, Toronto, Ontario

Princess Margaret Cancer Centre, Toronto, Ontario

CHUM Centre de Recherche, Montréal, Quebec

SMBD Jewish General Hospital, Montréal, Quebec

Fakultní nemocnice Brno, Brno, Not set

Fakultní nemocnice Hradec Králové, Hradec Králové, Not set

Fakultní nemocnice Olomouc, Olomouc, Not set

Thomayerova nemocnice, Prague, Not set

Nemocnice Na Homolce, Prague, Not set

Centre Georges François Leclerc, Dijon, Not set

CHU de Grenoble - Hôpital Nord, Grenoble, Not set

Institut Hospitalier Franco-Britannique, Levallois-Perret, Not set

Hôpital Cochin, Paris, Not set

ICO - Site René Gauducheau, Saint Herblain, Not set

Universitaetsklinikum Heidelberg, Heidelberg, Baden Wuerttemberg

Vivantes Klinikum Neukoelln, Berlin, Not set

Universitaetsklinikum Freiburg, Freiburg, Not set

Medizinische Hochschule Hannover, Hanover, Not set

Universitaetsklinikum Tuebingen, Tuebingen, Not set

Semmelweis Egyetem, Budapest, Not set

Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Budapest, Not set

Orszagos Onkologiai Intezet, Budapest, Not set

Debreceni Egyetem, Debrecen, Not set

Borsod-Abauj-Zemplen Megyei Kozponti Korhaz es Egyetemi Oktatokorhaz, Miskolc, Not set

Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, Szolnok, Not set

Ospedale Policlinico San Martino, Genova, Not set

IEO Istituto Europeo di Oncologia, Milano, Not set

Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Not set

IOV - Istituto Oncologico Veneto IRCCS, Padova, Not set

Azienda Ospedaliero Universitaria Pisana, Pisa, Not set

Centro Ricerche Cliniche di Verona S.r.l, Verona, Not set

CHA Bundang Medical Center, CHA University, Seongnam-si, Gyeonggi-do

Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do

Dong-A University Hospital, Pusan, Not set

Seoul National University Bundang Hospital, Seongnam-si, Not set

Korea University Anam Hospital, Seoul, Not set

Seoul National University Hospital, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Korea University Guro Hospital, Seoul, Not set

Severance Hospital, Yonsei University, Seoul, Not set

Asan Medical Center, Seoul, Not set

FSBSI "Russian Oncological Scientific Center n.a. N.N. Blokhin", Moscow, Not set

FSBSI Russian Oncological Scientific Center n.a. N.N. Blokhin, Moscow, Not set

"VitaMed" LLC, Moscow, Not set

State Budget Institution of Healthcare "Leningrad Regional Clinical Oncology Dispensary", Saint Petersburg, Not set

Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Not set

SPb SBIH "City Clinical Oncological Dispensary", Saint Petersburg, Not set

Medicinskiy gorod, Tyumen, Not set

Hospital Universitari Vall d'Hebron, Barcelona, Not set

Hospital Clinic de Barcelona, Barcelona, Not set

Hospital de la Santa Creu i Sant Pau, Barcelona, Not set

ICO l'Hospitalet - Hospital Duran i Reynals, L'Hospitalet De Llobregat, Not set

Hospital General Universitario Gregorio Marañon, Madrid, Not set

Hospital Universitario Clinico San Carlos, Madrid, Not set

Hospital Universitario HM Madrid Sanchinarro, Madrid, Not set

Hospital Universitario Virgen Macarena, Sevilla, Not set

Hospital Universitario Virgen del Rocio, Sevilla, Not set

Changhua Christian Medical Foundation Changhua Christian Hospital, Changhua, Not set

China Medical University Hospital, Taichung, Not set

National Taiwan University Hospital, Taipei, Not set

MacKay Medical Foundation The Presbyterian Church in Taiwan MacKay Memorial Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Acibadem Adana Hospital, Adana, Not set

Baskent University Adana Application and Research Center, Adana, Not set

Akdeniz University Medical Faculty, Antalya, Not set

Trakya University Medical Faculty, Edirne, Not set

Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty, Istanbul, Not set

Dr. Abdurrahman Yurtaslan Oncology Teaching and Research Hospital, Malatya, Not set

Inonu University Medical Facility, Malatya, Not set

CI Chernivtsi RC Oncological Dispensary, Chernivtsi, Not set

Communal Non-profit Enterprise Regional Center of Oncology, Kharkiv NMU, Kharkiv, Not set

CI of Healthcare Regional Clinical Specialized Dispensary of the Radiation Protection, Kharkiv, Not set

Kyiv City Clinical Oncological Center, Kyiv, Not set

SI "Shalimov's National Institute of Surgery and Transplantation" of NAMSU, Kyiv, Not set

Treatment-Prevention Institution Volyn Regional Oncological Dispensary, Luts'k, Not set

Communal Institution Odesa Regional Clinical Hospital, Odesa, Not set

RCI Sumy Regional Clinical Oncological Dispensary, Sumy, Not set

Guy's Hospital, London, Greater London

The Christie, Manchester, Greater Manchester

Western General Hospital, Edinburgh, Not set

Beatson West of Scotland Cancer Centre, Glasgow, Not set

Torbay Hospital, Torquay, Not set

The Clatterbridge Cancer Centre, Wirral, Not set

Conditions: Biliary Tract Cancer

Register for Updates

Learn More ›

ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers

NCT02351765

Completed

The purpose of this study is to determine the recommended phase II dose, and to assess the safety of acelarin in combination with cisplatin in patients with locally advanced/ metastatic biliary tract cancers.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/16/2023

Locations: Beatson Oncology Centre, Glasgow, Not set +4 locations

Conditions: Biliary Tract Cancer, Gallbladder Cancer, Cholangiocarcinoma, Ampullary Cancer

Register for Updates

Learn More ›

A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors

NCT02983045

Completed

In this four-part study, NKTR-214 was administered in combination with nivolumab and with/without other anticancer therapies. Part 1 considered escalating doublet (NKTR 214 + nivolumab) doses to determine the RP2D. Part 2 considered dose expansion cohorts for the doublet (NKTR 214 + nivolumab ± chemotherapy). Part 3 was schedule-finding for a triplet therapy (NKTR 214 + nivolumab + ipilimumab). Part 4 dose expansion for the triplet (NKTR 214 + nivolumab + ipilimumab) was planned to further asses... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

03/09/2023

Locations: UCSD, Moores Cancer Center, La Jolla, California +57 locations

UCSD, Moores Cancer Center, La Jolla, California

UCLA, Los Angeles, California

Stanford Cancer Institute, Stanford, California

University of Colorado, Denver, Denver, Colorado

Yale School of Medicine, New Haven, Connecticut

University of Florida, Gainesville, Florida

Orlando Health Inc., Orlando, Florida

Emory University Hospital, Atlanta, Georgia

Loyola University Medical Center, Chicago, Maywood, Illinois

Indiana University Health Melvin & Bren Simon Cancer Center, Indianapolis, Indiana

University of Kansas Cancer Center, Kansas City, Kansas

Dana-Farber Cancer Institute, Boston, Massachusetts

Henry Ford Hospital, Detroit, Michigan

Washington University School of Medicine in St. Louis, Saint Louis, Missouri

Roswell Park Cancer Institute, Buffalo, New York

New York University Langone Medical Center - NYU Cancer Institute, New York, New York

Memorial Sloan-Kettering Cancer Center, New York, New York

Providence Portland Medical Center, Portland, Oregon

The University of Texas MD Anderson Cancer Center, Houston, Texas

Inova Fairfax Hospital, Fairfax, Virginia

Virginia Cancer Specialists, PC, Fairfax, Virginia

Seattle Cancer Care Alliance, Seattle, Washington

Antwerp University Hospital, Edegem, Not set

Vzw Az Groeninge, Kortrijk, Not set

UZ Leuven, Leuven, Not set

CHU de Liège, Liège, Not set

GZA Ziekenhuizen Campus Sint-Augustinus, Wilrijk, Not set

BC Cancer Agency Vancouver Centre, Vancouver, British Columbia

Sunnybrook Health Sciences Centre, Toronto, Ontario

Princess Margaret Cancer Centre, Toronto, Ontario

Jewish General Hospital, Montréal, Quebec

L'Institut Paoli - Calmettes, Marseille, Brouches-duRhone

Institut de Cancerologie de l'Ouest, Saint-Herblain, Loire-Atlantique

Centre Léon Bérard, Lyon, Not set

Assistance Publique Hopitaux de Marseille - Hopital Nord, Marseille Cedex 20, Not set

Gustave Roussy, Villejuif, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Not set

Istituto Europeo di Oncologia, Milano, Not set

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Napoli, Not set

Azienda Ospedaliera San Camillo-Forlanini, Roma, Not set

Azienda Ospedaliera Universitaria Senese, Siena, Not set

Institute for Cancer Research and Treatment (IRCC), Turin, Not set

Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny im. Ks. B. Markiewicza, Brzozów, Not set

Szpitale Pomorskie Sp. z o.o., Gdynia, Not set

Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy, Otwock, Not set

Wielkopolskie Centrum Pulmonologii i Torakochirurgii, Poznań, Not set

Med-Polonia Sp. z o.o., Poznań, Not set

Instytut Medyczny Santa Familia Sp. z o. o. w Łodzi, Łódź, Not set

Hospital Quirón Barcelona, Barcelona, Not set

Hospital Clínic de Barcelona, Barcelona, Not set

Hospital Universitario Ramón y Cajal, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Not set

Clínica Universidad de Navarra, Pamplona, Not set

Campus Hospital Universitario Virgen del Rocío - Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Not set

The Royal Marsden NHS Trust, London, Not set

Mount Vernon Cancer Centre, Northwood, Not set

The Christie NHS Foundation Trust, Withington, Not set

Conditions: Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer, Urothelial Carcinoma, Triple Negative Breast Cancer, HR+/HER2- Breast Cancer, Gastric Cancer

Register for Updates

Learn More ›

Cisplatin Treatment Options in United Kingdom

Match to Clinical Trials